Stanford Medicine proposes building an integrated care and research center in Redwood City

OMB proposal to sideline peer review sparks widespread opposition
Nearly 500,000 public comments flood in—here are some highlights

The Trump administration’s effort to give political appointees greater authority over federally-funded science is colliding with fierce objections from researchers, universities, medical organizations, and members of Congress.

July 17, 2026

Vol.52 No.28

By Claire Marie Porter

The future of oncology: Early-career scientists need mentorship and a new academic model

The early years of a scientific career can be unforgiving.

July 17, 2026

Vol.52 No.28

By Marcel van den Brink

In Brief

Dartmouth raises over $12M for cancer research at 45th annual Prouty fundraiser

More than 4,700 participants, volunteers, donors, and supporters came together on July 11 to raise a record-breaking $12,010,204 for cancer research and patient support programs at Dartmouth Cancer Center.

July 17, 2026

Vol.52 No.28

Clinical Trials & Tribulations

Saving Western Kenya’s pediatric blood cancer patients
How flow cytometry is changing the diagnostic landscape

When our hematological malignancy testing pilot project began in Eldoret, Kenya, there seemed to be a mismatch in relation to progress in healthcare. The region, like much of sub-Saharan Africa, had been focusing on combatting infectious diseases such as HIV and malaria—which was much-needed—yet cancer care was under-resourced.

July 10, 2026

Vol.52 No.27

By Samuel (Tony) Boova, Eda Holl, LaToya Montgomery, Steve Kussick, Nicholas Kigen, Gilbert Olbara, Festus Muigai Njuguna, Terry Vik and Teresa Loile Lotodo

Clinical Roundup

Tumor-on-a-chip model shows how pancreatic cancer hijacks immune cells, UMiami study finds

A “tumor-on-a-chip” model is giving scientists a live look at how pancreatic cancer can recruit the body’s own immune cells to help tumors survive. The study reveals possible new targets to weaken the cancer’s defenses and make treatments work better.

July 10, 2026

Vol.52 No.27

Cancer Policy

AACR urges OMB to retract proposed rule on federally funded research

The American Association for Cancer Research is urging the White House Office of Management and Budget to rescind its recent proposed rule that would give the administration unprecedented political control over government-funded science.

July 02, 2026

Vol.52 No.26

By Sara Willa Ernst

Stanford Medicine proposes building an integrated care and research center in Redwood City

YOU MAY BE INTERESTED IN

OMB proposal to sideline peer review sparks widespread opposition
Nearly 500,000 public comments flood in—here are some highlights

The future of oncology: Early-career scientists need mentorship and a new academic model

Dartmouth raises over $12M for cancer research at 45th annual Prouty fundraiser

Saving Western Kenya’s pediatric blood cancer patients
How flow cytometry is changing the diagnostic landscape

Tumor-on-a-chip model shows how pancreatic cancer hijacks immune cells, UMiami study finds

AACR urges OMB to retract proposed rule on federally funded research

Renew today!

Subscriber content

Never miss an issue!

Login

Stanford Medicine proposes building an integrated care and research center in Redwood City

YOU MAY BE INTERESTED IN

OMB proposal to sideline peer review sparks widespread oppositionNearly 500,000 public comments flood in—here are some highlights

The future of oncology: Early-career scientists need mentorship and a new academic model

Dartmouth raises over $12M for cancer research at 45th annual Prouty fundraiser

Saving Western Kenya’s pediatric blood cancer patientsHow flow cytometry is changing the diagnostic landscape

Tumor-on-a-chip model shows how pancreatic cancer hijacks immune cells, UMiami study finds

AACR urges OMB to retract proposed rule on federally funded research

Never miss an issue!

Login

OMB proposal to sideline peer review sparks widespread opposition
Nearly 500,000 public comments flood in—here are some highlights

Saving Western Kenya’s pediatric blood cancer patients
How flow cytometry is changing the diagnostic landscape